Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
NCT03241927
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
difficult enrollment
Conditions
Melanoma
Interventions
BIOLOGICAL:
Pembrolizumab
Sponsor
Nina Bhardwaj